Filters

Pp-177 manufacturers

Filters

None products found

pp-177

Tablets, enteric coated

Dossier type
CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
Indication: Prevention of norovirus gastroenteritis (GII.4 and GI.1 strains) in adults Clinical stage: Phase 2b — safety and immunogenicity study ongoing Modality: Biologic (recombinant adenovirus type 5 oral tablet vaccine; second-generation) Mechanism / Target: Oral adenovirus vector expressing norovirus VP1 capsid protein — induces mucosal IgA in gut (critical for norovirus protection) and systemic IgG; T-cell responses Route / form: Oral tablet (enteric-coated; room-temperature stable) Differentiation: Only oral norovirus vaccine candidate; mucosal IgA induction matches route of infection; no cold chain required; 25× greater fecal IgA than first-generation; no injectable alternative exists
Manufacturer #39196

Clinical-stage vaccine company pioneering oral tablet vaccines using an adenovirus vector platform. Develops thermostable, room-temperature-stable oral vaccines to replace injectable immunisations. Wholly owned norovirus and COVID-19 oral vaccine programmes advancing in Phase 2.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.